Marine Compounds and Cancer 2020
Basel, Switzerland: MDPI - Multidisciplinary Digital Publishing Institute, 2021
Online
E-Book
- 480
The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U®), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.
Titel: |
Marine Compounds and Cancer 2020
|
---|---|
Autor/in / Beteiligte Person: | Honecker, Friedemann ; Dyshlovoy, Sergey A. |
Link: | |
Veröffentlichung: | Basel, Switzerland: MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Medientyp: | E-Book |
Umfang: | 480 |
ISBN: | 978-3-0365-0630-2 (print) ; 978-3-0365-0631-9 (print) |
DOI: | 10.3390/books978-3-0365-0631-9 |
Schlagwort: |
|
Sonstiges: |
|